Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.

Leong SP, Kim J, Ross M, Faries M, Scoggins CR, Metz WL, Cope FO, Orahood RC.

Ann Surg Oncol. 2011 Apr;18(4):961-9. doi: 10.1245/s10434-010-1524-z. Epub 2011 Feb 18.

2.

Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma.

Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SP, Faries MB, Averbook BJ, Martinez SR, Puleo CA, Messina JL, Christman L, Wallace AM.

Ann Surg Oncol. 2013 Feb;20(2):680-8. doi: 10.1245/s10434-012-2612-z. Epub 2012 Oct 3.

3.

Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.

Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR.

Ann Surg Oncol. 2013 Aug;20(8):2590-9. doi: 10.1245/s10434-013-2887-8. Epub 2013 Mar 17.

4.

Use of 99mTc-Tilmanocept as a Single Agent for Sentinel Lymph Node Identification in Breast Cancer: A Retrospective Pilot Study.

Unkart JT, Wallace AM.

J Nucl Med Technol. 2017 Sep;45(3):181-184. doi: 10.2967/jnmt.117.194415. Epub 2017 Jul 13.

PMID:
28705929
5.

The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care.

Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera DR, Wallace AM.

Clin Exp Metastasis. 2012 Oct;29(7):681-6. doi: 10.1007/s10585-012-9497-x. Epub 2012 Jun 23. Review.

PMID:
22729510
6.
7.

Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.

Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM.

Ann Surg Oncol. 2015 Jan;22(1):40-5. doi: 10.1245/s10434-014-3892-2. Epub 2014 Jul 29.

9.

[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.

Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Hall NC, Carroll WR, Smith RB, Zitsch RP, Lee WT, Shnayder Y, Cognetti DM, Pitman KT, King DW, Christman LA, Lai SY.

Ann Surg Oncol. 2015 Oct;22(11):3708-15. doi: 10.1245/s10434-015-4382-x. Epub 2015 Feb 11.

10.

Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.

Unkart JT, Hosseini A, Wallace AM.

J Surg Oncol. 2017 Dec;116(7):819-823. doi: 10.1002/jso.24735. Epub 2017 Jul 10.

PMID:
28695567
11.

A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging.

Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR.

Radiology. 2012 Oct;265(1):186-93. Epub 2012 Jul 2.

12.
13.

99mTc-Tilmanocept: A Novel Molecular Agent for Lymphatic Mapping and Sentinel Lymph Node Localization.

Surasi DS, O'Malley J, Bhambhvani P.

J Nucl Med Technol. 2015 Jun;43(2):87-91. doi: 10.2967/jnmt.115.155960. Epub 2015 May 8. Review.

14.
15.

Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping.

Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM.

Nucl Med Biol. 2003 Nov;30(8):805-10.

PMID:
14698783
16.

Sentinel node detection in cervical cancer with (99m)Tc-phytate.

Silva LB, Silva-Filho AL, Traiman P, Triginelli SA, de Lima CF, Siqueira CF, Barroso A, Rossi TM, Pedrosa MS, Miranda D, Melo JR.

Gynecol Oncol. 2005 May;97(2):588-95.

PMID:
15863164
18.

Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.

Lawson LL, Sandler M, Martin W, Beauchamp RD, Kelley MC.

Am Surg. 2004 Dec;70(12):1050-5; discussion 1055-6.

PMID:
15663043
19.

99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.

Bedrosian I, Scheff AM, Mick R, Callans LS, Bucky LP, Spitz FR, Helsabeck C, Elder DE, Alavi A, Fraker DF, Czerniecki BJ.

J Nucl Med. 1999 Jul;40(7):1143-8.

20.

Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping.

Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR.

Ann Surg Oncol. 2007 Feb;14(2):913-21. Epub 2006 Dec 5.

PMID:
17146742

Supplemental Content

Support Center